Fundraising Fox
Cambridge · Seed–Series A · 1 people tracked
Also known as QIMING U.S. VENTURES MANAGEMENT, LLC
Find your way into Qiming Venture Partners USA
90 people in our graph share verified history with the Qiming Venture Partners USA team — schools, employers, funds. One of them is your warm intro.
Investment thesis
The firm positions itself as a hands-on partner to healthcare companies, bringing deep technical expertise, operational experience, an expansive network, and a global mindset. Having built and shaped companies from both the founder and investor sides, the team supports portfolio companies throughout their lifecycle — from early concept through regulatory approval and commercialization — with the aim of making a lasting impact in healthcare.
Source: firm website, verified Sep 22, 2026.
Team · 1 people
from curated
What they invest in
from 8 of 9 portfolio companiesBiotech ×6Healthtech ×3AI & Machine Learning ×2Data & Infrastructure ×2Enterprise Software ×2Deep Tech ×1Developer Tools ×1
HQs:United States×9
Investments · 9 tracked
founders shown can be your intro pathBy year:2025 · 42021 · 12020 · 12019 · 12017 · 18 dated
Korro Bio is a biotechnology company developing a new class of RNA-editing therapies guided by human genetics and disease biology.
BiotechHealthtechCambridge, US
Nessan Bermingham(Mr. Bermingham is the Executive Chair of the Issuer.)inJean-François Formela(Director)inOmmer Chohan(Mr. Chohan is the Secretary and Treasurer of the Issuer.)inRam Aiyar(Chief Executive Officer, President and Director)inTodd Chappell(Chief Operating Officer)in
BoardJean-Francois Formela(Director)in
Co-investorsAtlas VentureMC Healthcare VenturesNew Enterprise Associates (NEA)AlexandriaRock Springs CapitalTaiwania Capital+1 more
Umoja Biopharma develops in vivo CAR T cell cancer therapies using its VivoVec platform, which generates chimeric antigen receptor T cells directly inside a patient's body rather than through the traditional ex vivo process.
BiotechHealthtechSeattle, US
Andrew M. Scharenberg(Executive Officer, Director)Philip S. Low(Director)
BoardIrena Melnikova(Executive Officer)Anna French(Director)Robert Glassman(Director)John Hamer(Director)in
Co-investorsMPM BioImpactDCVC BioSoftBank GroupK2 HealthVenturesSoftBank Vision FundDCVC (Data Collective)
Dualitas Therapeutics develops bispecific antibody therapies that pair a proprietary proximity engager arm with an antibody against a therapeutic target, using its DualScreen discovery engine to identify synergistic target combinations.
BiotechDeep TechSouth San Francisco, US
Forbes Huang(Co-Founder, Chief Operating Officer & Chief Business Officer)inGreg Lazar(Co-Founder & Chief Scientific Officer)inRichard Murray(Executive Officer, Director)Karim Dabbagh(Chief Executive Officer, Board Member)in
BoardAlicia Levey(Director)Michael Ross(Director)
Co-investorsQiming Venture PartnersSV Health InvestorsVersant VenturesAlexandriaDementia Discovery FundQiming Healthcare
Renasant Bio is a biopharmaceutical company developing oral small molecule corrector and potentiator therapies to restore the function of polycystin 1 and 2 proteins in autosomal dominant polycystic kidney disease (ADPKD).
BiotechHealthtechBerkeley, US
Jeremy Reiter(Scientific Co-Founder)Markus Delling(Scientific Co-Founder)Thomas Gustafson(Executive Officer)inEmily Conley(Executive Officer, Director)in
BoardEvan Caplan(Director)inCharlotte McKee(Director)
Co-investors5AM VenturesOrbiMedAtlas Venture
Rhino builds a system of record for enterprise business logic, rules, and decisions that are typically scattered across legacy systems and processes.
AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareAlexandria, US
Adam Branch(Executive Officer, Director, Promoter)
BoardHarrison Touati(Director)Jon Galitzer(Director)
Co-investorsKoch Disruptive TechnologiesLionBirdMitsui Global InvestmentAlleyCorpGaingelsTiger Global Management+1 more
__Twitter.png)
Rhino Federated Computing provides enterprise software infrastructure enabling organizations to run AI, analytics, and data workflows across distributed data environments while preserving privacy and security.
AI & Machine LearningData & InfrastructureEnterprise SoftwareBoston, US
Dr. Ittai DayaninIttai Dayan(Dr.)inYuval Baror(Founder)inChristopher Laws(Executive Officer)
BoardEdward Michael(Director)inIvneet Bhullar(Director)in
Co-investorsAlleyCorpE12 Venture Capital, LlcFusionLionBirdMitsui Global InvestmentAlley Robotics Ventures+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Exits · 1
1 IPOsKorro BioNASDAQ: KRRO
Frequently asked questions
- How many investments has Qiming Venture Partners USA made?
- Qiming Venture Partners USA has 9 tracked investments, 1 of which have exited, including 4 dated in the last 24 months.
- What stage does Qiming Venture Partners USA invest at?
- Qiming Venture Partners USA invests at the Seed, Series A stages.
- What sectors does Qiming Venture Partners USA focus on?
- Qiming Venture Partners USA focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Qiming Venture Partners USA located?
- Qiming Venture Partners USA is headquartered in Cambridge, US.
- Does Qiming Venture Partners USA lead rounds?
- Qiming Venture Partners USA typically participates in rounds rather than leading them.
Co-investors · 7
.png)
General Catalyst is a venture capital firm operating as a partnership focused on company building and accelerating the growth of the businesses it backs.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Techstars is a startup accelerator and early-stage investor that funds ambitious founders and provides capital, mentorship, and access to a global network of investors, operators, and corporate partners.
RA Capital Management is a healthcare and planetary health investment firm that founds, funds, and scales companies using scientific diligence, multi-stage capital, and hands-on operational support.
Apollo Health Ventures is a biotech-focused investor that combines traditional funding with venture building to back transformative healthcare and longevity companies in Europe and the US.
1955 Capital is an early-stage, thesis-driven venture firm founded in 2016 that invests in companies commercializing foundational science across biology, materials, energy, and computation.
Firms observed investing alongside Qiming Venture Partners USA, from public investor directories. Shared companies are the overlap with Qiming Venture Partners USA's recorded portfolio.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.